Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-15

Clinical Trial Update: 68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 68Ga-NY104 PET/CT imaging in renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 68Ga-NY104 (Gallium-68 NY104 PET tracer)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN